FDA approves Alexion’s Soliris for another rare disease; Sun Pharma debuts companion mobile app for acne drug; Hurricane halts manufacturing in Puerto Rico
Five things for pharma marketers to know: Monday, October 23, 2017
An FDA advisory committee is scheduled to vote Wednesday on whether to approve Novo’s semaglutide, which, if approved, could steal market share from Eli Lilly’s Trulicity.
Five things for pharma marketers to know: Monday, October 16, 2017